We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
News

USDA to Research Cosmetic Hemp Products

An agency of the United States Department of Agriculture (USDA) has set out a research project to help expand the US hemp oil market.

Read More

CBD for Pain Relief is More Than the Placebo Effect, Study Finds

Scientists at Syracuse University have demonstrated that CBD users benefit both from the psychological expectation and the real pharmacological effects of the drug.

Read More

Cannabis Users With Heart Rhythm Problems Face Increased Mortality Risk, Study Warns

Hospitalized cannabis users with a heart arrhythmia were 4.5 times more likely to die in hospital than those without heart rhythm problems, the study found.

Read More

UK Hemp Groups Oppose a Proposed 0.03% THC Limit for CBD Products

The debate on THC restrictions and CBD regulations in the UK continues.

Read More

Cancer Patients Get Sleep Benefits From Medical Cannabis, Finds Study

In a new study, many cancer patients reported significant improvements in sleep disruptions and a decreased use of other medication for insomnia.

Read More

UK’s Food Standards Agency Begins Processing CBD Applications

The UK’s de facto CBD regulator has begun approving CBD food products for sale.

Read More

Nevada Considers Removing Label Requirement for Radiation-Treated Cannabis

The Nevada Cannabis Compliance Board (CCB) are considering changes to its state cannabis regulations which would remove the requirement for cannabis treated with irradiation to display the international symbol for irradiation, the Radura.

Read More

Oklahoma Cannabis Testing Lab Loses License

State authorities in Oklahoma have revoked the license of a medical cannabis testing lab on the grounds of public health and safety.

Read More

Cannabis Users With Genetic Markers for Schizophrenia Are More Likely to Have Psychotic Episodes, Study Finds

The paper found that, while cannabis consumers have higher rates of psychotic experiences than non-consumers, the difference was indeed more pronounced among those with a high genetic predisposition to schizophrenia.

Read More

 
Advertisement